In X-linked chronic granulomatous disease, the insertion of the CYBB gene (encoding the gp91phox subunit of NADPH oxidase) into the AAVS1 site of patient-derived CD34+ HSCs restored gp91phox expression and NADPH oxidase activity in ex vivo–derived neutrophils [178]. This evidence concerns the gene FMO5 and chronic granulomatous disease.